<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-82030" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Primary Progressive Aphasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kiymaz</surname>
            <given-names>Tunc</given-names>
          </name>
          <aff>Temple University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan Suheb</surname>
            <given-names>Mahammed Z.</given-names>
          </name>
          <aff>University of Wisconsin</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lui</surname>
            <given-names>Forshing</given-names>
          </name>
          <aff>CA Northstate Uni, College of Med</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tunc Kiymaz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mahammed Khan Suheb declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Forshing Lui declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-82030.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Aphasia is the inability to understand, formulate, or vocalize spoken or written language. Primary progressive aphasia (PPA) refers to the group of neurodegenerative diseases showing gradual speech and language impairment as the primary presenting symptom without significant cognitive, physical, or behavioral components.</p>
        <p>Classic aphasia typically arises suddenly, as seen in stroke. In contrast, PPA develops gradually, impairing language functions over time. The condition can be classified as semantic, nonfluent agrammatic, or logopenic, depending on the patient's predominant deficits. PPA has no cure, and the condition progresses with time. However, depending on disease subtype and individual factors, the appropriate management approach can help maintain functional abilities and enhance quality of life for patients with PPA and their caregivers.</p>
        <p>This activity for healthcare workers enhances learners' proficiency in evaluating and managing PPA. The activity aims to improve participants' understanding of the condition's neuroanatomical and neuropathological bases, subtypes, diagnostic criteria, evaluation strategies, and treatment options. Learners become equipped to contribute meaningfully to an interprofessional team caring for patients with PPA.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the&#x000a0;signs and symptoms suggestive of&#x000a0;primary progressive aphasia.</p></list-item><list-item><p>Create a clinically appropriate diagnostic plan for an individual with suspected&#x000a0;primary progressive aphasia.</p></list-item><list-item><p>Develop a personalized management plan for a patient diagnosed with&#x000a0;primary progressive aphasia.</p></list-item><list-item><p>Apply effective strategies to improve care coordination among interprofessional team members to facilitate positive outcomes for patients&#x000a0;with&#x000a0;primary progressive aphasia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=82030&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=82030">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-82030.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>
<bold>Primary Progressive Aphasia Overview</bold>
</p>
        <p>Aphasia is a language disorder arising from damage to a specific brain area controlling language comprehension, formulation, and expression. Primary progressive aphasia (PPA) refers to a group of neurodegenerative diseases in which gradual speech and language impairment are the primary presenting symptoms,&#x000a0;unaccompanied by marked cognitive, physical, or behavioral changes.<xref ref-type="bibr" rid="article-82030.r1">[1]</xref> Classic aphasia occurring after conditions such as stroke develops abruptly, but PPA has a gradual onset.&#x000a0;</p>
        <p>PPA characterization and differentiation based on linguistic and nonlinguistic profiles are now easier to accomplish due to extensive research. Advanced neuroimaging techniques like diffusion-weighted imaging (DWI) and resting-state functional magnetic resonance imaging (fMRI) allow healthcare providers to go beyond distinct focal gray matter atrophy patterns to a deeper understanding of PPA's effects on structural and functional connectivity changes. However, despite significant diagnostic advances, a clear consensus on its pathology remains elusive. Nevertheless, improved PPA characterization may positively impact patient management.</p>
        <p>Fluent aphasia refers to deficits related to comprehension and is usually associated with Wernicke brain area pathologies. In contrast, nonfluent aphasias produce a failure in written or verbal language expression and are often associated with Broca brain area lesions. The general concept of a primary progressive language impairment disease process without cognitive effects was first described in the 1890s by Pick and Serieux. However, Mesulam is presently credited for exploring "slowly progressive aphasia" and coining its name in the 1980s.<xref ref-type="bibr" rid="article-82030.r2">[2]</xref>&#x000a0;"Slowly progressive aphasia" was later renamed in the literature as "primary progressive aphasia."<xref ref-type="bibr" rid="article-82030.r3">[3]</xref></p>
        <p>PPA is closely related to Alzheimer and Pick diseases. Thus, PPA classification and diagnosis can sometimes be controversial.<xref ref-type="bibr" rid="article-82030.r4">[4]</xref>&#x000a0;PPA's 3 main variants are nonfluent/agrammatic (nfvPPA), semantic (svPPA), and logopenic (lvPPA).<xref ref-type="bibr" rid="article-82030.r5">[5]</xref>&#x000a0;PPA presents similarly to primary progressive apraxia, a gradual, degenerative disorder affecting the planning, programming, and execution of sensorimotor commands required for speech production.<xref ref-type="bibr" rid="article-82030.r6">[6]</xref>&#x000a0;Pathologically,&#x000a0;nfvPPA is&#x000a0;grouped under the frontotemporal dementia (FTD) syndromes. In contrast, the logopenic variant is frequently classified as an atypical Alzheimer disease form.</p>
        <p>
<bold>Anatomical Considerations for PPA</bold>
</p>
        <p>In PPA, neuroanatomical changes primarily affect brain regions associated with language processing. The specific areas vary depending on the PPA subtype, but commonly involved brain regions affect left-hemisphere language functions. The Broca area within the left inferior frontal gyrus' posterior portion is responsible for language production and grammar. The Wernicke area within the left superior temporal gyrus' posterior aspect is involved in language comprehension. The angular gyrus at the parietal, temporal, and occipital lobe junction is implicated in semantic processing and reading. The left temporal lobe is crucial in language processing, including semantic memory and word retrieval. Damage to these areas can lead to word-finding and semantic knowledge deficits.</p>
        <p>The frontal lobes, especially the left inferior frontal gyrus, are involved in language production, grammar, and articulation. Injury to these areas results in nonfluent or agrammatic speech. The parietal lobes, including the angular gyrus, contribute to language processing, particularly in reading and semantic comprehension. Damage to these regions can impair reading comprehension and semantic processing. Some PPA cases may also affect posterior language areas beyond the traditional language cortex. These areas include regions involved in visual processing and multisensory integration, impacting reading and comprehension abilities. Understanding PPA's neuroanatomical basis is crucial for accurate diagnosis, prognosis estimation, and developing targeted interventions tailored to individual patients' specific language deficits and affected brain regions.</p>
      </sec>
      <sec id="article-82030.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>PPA is a group of neurodegenerative disorders primarily affecting the language (dominant) areas of the brain. The disorder is usually considered an FTD subtype. Since 2011, FTD has been classified clinically and pathologically into the more common behavioral variant (bvFTD) and primary progressive aphasia (PPA).<xref ref-type="bibr" rid="article-82030.r7">[7]</xref>&#x000a0;The 3 PPA variants arise from neurodegenerative changes in different brain areas. The semantic and nonfluent variants are related to FTD, while the logopenic type resembles Alzheimer disease more closely. The semantic variant mainly affects the anterior temporal region. The nonfluent variant impacts the inferior frontal gyrus and precentral cortex regions. The logopenic variant involves the left posterior superior and middle temporal gyri and inferior parietal lobule.<xref ref-type="bibr" rid="article-82030.r8">[8]</xref><bold>&#x000a0;</bold>The etiology in each type is detailed below.</p>
        <p>
<bold>Nonfluent or Agrammatic PPA Variant</bold>
</p>
        <p>NfvPPA is most commonly associated with an FTD-4R tau protein form.<xref ref-type="bibr" rid="article-82030.r9">[9]</xref><xref ref-type="bibr" rid="article-82030.r10">[10]</xref><xref ref-type="bibr" rid="article-82030.r11">[11]</xref>&#x000a0;Other reports indicate TDP-43-A pathology in nfvPPA. Some nfvPPA cases are associated with progranulin (<italic toggle="yes">PGRN</italic>) or chromosome 9 open reading frame 72 (<italic toggle="yes">C9orf72</italic>) gene mutations.<xref ref-type="bibr" rid="article-82030.r12">[12]</xref>&#x000a0;Less frequently, Alzheimer disease pathology has also been reported in nfvPPA. The 3 genes primarily associated with&#x000a0;FTD are microtubule-associated protein tau (<italic toggle="yes">MAPT</italic>), granulin (<italic toggle="yes">GRN</italic>), and&#x000a0;<italic toggle="yes">C9orf72</italic>. Frontotemporal lobar degeneration is frequently associated with nfvPPA. Interestingly, prospectively recruited cohorts of PPA suggest mutations are rarely the cause of nfvPPA.<xref ref-type="bibr" rid="article-82030.r13">[13]</xref></p>
        <p>NfvPPA is the most variable of the PPAs and lacks clinicopathologic associations.&#x000a0;<italic toggle="yes">GRN</italic>&#x000a0;gene mutations on chromosome 17q21.31, which encodes for a protein called "progranulin," have been identified in 2 families with PPA.<xref ref-type="bibr" rid="article-82030.r14">[14]</xref>&#x000a0;These mutations are associated with bvFTD.</p>
        <p>
<bold>Semantic PPA Variant</bold>
</p>
        <p>SvPPA is nearly always associated with underlying TDP-43-C pathological aggregates found in 75&#x02013;100% of cases in clinicopathological correlation series. This variant is most often associated with FTD tau in the remainder of patients.&#x000a0;SvPPA is most consistently associated with left (dominant) temporal lobe pathology.<xref ref-type="bibr" rid="article-82030.r15">[15]</xref></p>
        <p>
<bold>Logopenic PPA Variant</bold>
</p>
        <p>LvPPA is most often caused by Alzheimer disease pathology in as many as 95% of cases.<xref ref-type="bibr" rid="article-82030.r16">[16]</xref>&#x000a0;This condition is recognized as one of the potential focal and early-onset presentations of Alzheimer disease, although other pathological profiles such as Lewy body dementia, TDP-43, and tau have been less commonly reported.<xref ref-type="bibr" rid="article-82030.r17">[17]</xref></p>
      </sec>
      <sec id="article-82030.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>PPA's prevalence is estimated to be 3 to 4 per 100,000 population.<xref ref-type="bibr" rid="article-82030.r18">[18]</xref>&#x000a0;A recent registry study revealed that this condition's incidence was around 1.14 per 100,000 person-years, compared with 35.7 per 100,000 person-years for Alzheimer disease.<xref ref-type="bibr" rid="article-82030.r19">[19]</xref>&#x000a0;The nfvPPA's prevalence is approximately 0.5 to 3.9 per 100,000 people. Men and women are equally affected, with an average age of about 60. No demographic, environmental, or socioeconomic risk factors have been identified. Approximately 56% to 86% of individuals with PPA have coexisting speech apraxia. A recent study showed that bvFTD was more common in men, whereas PPA was more common in women.<xref ref-type="bibr" rid="article-82030.r20">[20]</xref></p>
      </sec>
      <sec id="article-82030.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathology underlying svPPA mainly involves the atrophy and hypometabolism of the anterior temporal lobes, particularly the temporal poles, with a notable left-sided predominance. In 80% of cases, svPPA exhibits aggregates of&#x000a0;TAR DNA-binding protein 43kDa (TDP-43), similar to the pathological features observed in FTD and amyotrophic lateral sclerosis.</p>
        <p>The pathophysiology of nfvPPA remains under investigation. This condition exhibits more pathology and disease progression variability than other PPA types. However, involvement of the dominant inferior frontal lobe (Broca area) is consistently observed, with atrophy of the insular cortex in the dominant hemisphere also common.<xref ref-type="bibr" rid="article-82030.r21">[21]</xref>&#x000a0;This condition's variability coincides with brain regions associated with language output, sentence processing, and motor speech programming. The pronounced variability of nfvPPA compared to other variants persists histologically and remains a subject of investigation. Many patients exhibit abnormal tau deposition upon postmortem examination, while a minority may show signs of TDP-43 or Alzheimer pathology.</p>
        <p>Meanwhile, lvPPA is most commonly an aphasic Alzheimer disease variant. Patients most frequently develop the typical clinical Alzheimer disease features. The pathology is similar to Alzheimer disease but with more left-sided perisylvian or parietal atrophy. Similar to Alzheimer disease, lvPPA also has amyloid and hyperphosphorylated tau accumulation.</p>
      </sec>
      <sec id="article-82030.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most individuals with PPA have progressive cognitive impairment or dementia with aphasia as the dominant symptom during the first couple of years of the disease course. This presentation differs from other dementia forms, which often have language involvement as a late symptom. Obtaining the history of a progressive language problem that worsens over time is crucial. The symptom differs from acute stroke, which has a sudden onset and is nonprogressive.</p>
        <p>The neurologic examination in patients with PPA focuses on assessing language comprehension, expression, and fluency, including verbal and written communication skills. Additionally, cognitive functions such as memory, executive function, and visuospatial abilities are evaluated to rule out other neurodegenerative disorders. Motor function, sensory perception, and reflexes are also assessed to exclude neurological conditions mimicking PPA.</p>
        <p>The clinical features and exam findings of each PPA variant are explained below.</p>
        <p>
<bold>History and Physical Examination Features of NfvPPA</bold>
</p>
        <p>The hallmark clinical features of nfvPPA are effortful speech and agrammatism. Effortful speech is characterized by slow, labored speech production, mainly due to a speech motor-planning deficit, ie, apraxia of speech (AOS).<xref ref-type="bibr" rid="article-82030.r22">[22]</xref>&#x000a0;Speech sound or phonemic errors, such as distortions, deletions, substitutions, insertions, and transpositions, may be present. Distortions are phonetic errors caused by AOS. Deletions, substitutions, insertions, and transpositions are phonemic errors that may arise from a motor speech impairment or phoneme selection deficit.<xref ref-type="bibr" rid="article-82030.r23">[23]</xref><xref ref-type="bibr" rid="article-82030.r24">[24]</xref>&#x000a0;However, these 2 error types are often difficult to distinguish clinically. Research shows higher phonetic or phonemic error rates in patients with nfvPPA.<xref ref-type="bibr" rid="article-82030.r25">[25]</xref>&#x000a0;Other cognitive deficits may emerge as the disease progresses, including a decline in attentional resources, verbal working memory, executive functions, episodic memory, and praxis. Behavioral changes may also appear.<xref ref-type="bibr" rid="article-82030.r26">[26]</xref></p>
        <p>The clinical criteria for diagnosing nfvPPA require at least 1 core feature, either agrammatism or effortful speech with inconsistent errors. Additionally, at least 2 of the following must be present: impaired comprehension of complex sentences, preserved single-word comprehension, and preserved object knowledge.</p>
        <p>
<bold>History and Physical Examination Features of SvPPA</bold>
</p>
        <p>Individuals with svPPA typically experience a gradual decline in their ability to understand and use words correctly, resulting in severe and progressive difficulties in word retrieval (anomia) and comprehension of single words. The patients' speech output is fluent. Naming and single-word comprehension deficits are more prominent for low-frequency or low-familiarity items (eg, "rhinoceros" vs. "dog") in the illness' earlier stages.<xref ref-type="bibr" rid="article-82030.r27">[27]</xref>&#x000a0;Patients often replace less frequent words with more familiar ones, typically using the superordinate category (eg, "animal" for "cat"). Anomia may also be observed in spontaneous speech, often empty and not very informative.<xref ref-type="bibr" rid="article-82030.r28">[28]</xref></p>
        <p>Early in the disease course, patients with svPPA may struggle to understand unfamiliar words, often leading to anomia. These individuals frequently ask for the meaning of words as a symptom. The progression of semantic deficits leads to impaired object recognition affecting all sensory modalities, including vision, touch, olfaction, and gustation. Object familiarity strongly influences the ability to correctly identify objects, eg, a fork may be more familiar to the patient than a compass. Additionally, individuals with svPPA appear to have disproportionate difficulty understanding concrete concepts relative to abstract concepts.<xref ref-type="bibr" rid="article-82030.r29">[29]</xref></p>
        <p>Episodic memory is relatively preserved in svPPA, especially when tasks with minimal conceptual loading are used.<xref ref-type="bibr" rid="article-82030.r30">[30]</xref>&#x000a0;Behavioral abnormalities are typically present in mid-to-late phases, including disinhibition, irritability, and food taste changes (eg, developing a preference for sweet foods). Lack of empathy, mental inflexibility, and compulsions, including clockwatching and intense interest in jigsaw puzzles, are also frequently noted.<xref ref-type="bibr" rid="article-82030.r31">[31]</xref></p>
        <p>The current diagnostic guidelines identify anomia and single-word comprehension deficits as core features, and both are essential for diagnosis. At least 3 of the following diagnostic features must also be present: impaired object knowledge (especially for less common items), surface dyslexia or dysgraphia, intact repetition, and preserved speech production (grammar and motor skills).</p>
        <p>
<bold>History and Physical Examination Features of LvPPA</bold>
</p>
        <p>Patients with lvPPA typically present with word-finding difficulty, sentence repetition deficits, and, as the disease progresses, impaired sentence comprehension. Phonological impairments and, specifically, a phonological short-term memory deficit have been suggested to be the core of the syndrome.<xref ref-type="bibr" rid="article-82030.r32">[32]</xref>&#x000a0;Single-word repetition and comprehension remain largely spared. Longitudinal studies indicate faster cognitive decline in lvPPA than other variants, impacting not only language but also visuospatial abilities.<xref ref-type="bibr" rid="article-82030.r33">[33]</xref>&#x000a0;</p>
        <p>To diagnose lvPPA, impairments in both single-word retrieval (in spontaneous speech and naming) and sentence repetition are required. At least 3 of the following features must also be present: phonological errors in spontaneous speech and naming, preserved single-word comprehension and object knowledge, intact motor speech, and absence of clear agrammatism.</p>
        <p>The clinical features of the 3 PPA variants are summarized as follows:&#x000a0;</p>
        <table-wrap id="article-82030.table0" position="float" orientation="portrait">
          <table style="height: 307px; width: 809px;">
            <tbody>
              <tr>
                <td style="width: 147.062px; text-align: center;" rowspan="1" colspan="1">
<bold>Clinical Features</bold>
</td>
                <td style="width: 204.083px; text-align: center;" rowspan="1" colspan="1">
<p><bold>Nonfluent/Agrammatic Variant (NfvPPA)</bold></p>
</td>
                <td style="width: 236.615px; text-align: center;" rowspan="1" colspan="1">
<p><bold>Semantic Variant (SvPPA)</bold></p>
</td>
                <td style="width: 196.573px; text-align: center;" rowspan="1" colspan="1">
<p><bold>Logopenic Variant (LvPPA)</bold></p>
</td>
              </tr>
              <tr>
                <td style="width: 147.062px;" rowspan="1" colspan="1">
<p>Spontaneous speech</p>
</td>
                <td style="width: 204.083px;" rowspan="1" colspan="1">
<p>Nonfluent, short grammatically flawed</p>
</td>
                <td style="width: 236.615px;" rowspan="1" colspan="1">
<p>Fluent, profound impairment of object knowledge</p>
</td>
                <td style="width: 196.573px;" rowspan="1" colspan="1">
<p>Fluent, with frequent word-finding pauses</p>
</td>
              </tr>
              <tr>
                <td style="width: 147.062px;" rowspan="1" colspan="1">
<p>Naming</p>
</td>
                <td style="width: 204.083px;" rowspan="1" colspan="1">
<p>Relatively normal with phonemic errors</p>
</td>
                <td style="width: 236.615px;" rowspan="1" colspan="1">
<p>Highly impaired with paraphasic errors</p>
</td>
                <td style="width: 196.573px;" rowspan="1" colspan="1">
<p>Impaired</p>
</td>
              </tr>
              <tr>
                <td style="width: 147.062px;" rowspan="1" colspan="1">
<p>Repetition</p>
</td>
                <td style="width: 204.083px;" rowspan="1" colspan="1">
<p>Nonfluent</p>
</td>
                <td style="width: 236.615px;" rowspan="1" colspan="1">
<p>Relatively normal&#x000a0;</p>
</td>
                <td style="width: 196.573px;" rowspan="1" colspan="1">
<p>Impaired sentence repetition is a core feature</p>
</td>
              </tr>
              <tr>
                <td style="width: 147.062px;" rowspan="1" colspan="1">
<p>Comprehension</p>
</td>
                <td style="width: 204.083px;" rowspan="1" colspan="1">
<p>Relatively intact</p>
</td>
                <td style="width: 236.615px;" rowspan="1" colspan="1">
<p>Severe impairment, even at single-word level</p>
</td>
                <td style="width: 196.573px;" rowspan="1" colspan="1">
<p>Relatively intact</p>
</td>
              </tr>
              <tr>
                <td style="width: 147.062px;" rowspan="1" colspan="1">
<p>Reading</p>
</td>
                <td style="width: 204.083px;" rowspan="1" colspan="1">
<p>Intact for short items</p>
</td>
                <td style="width: 236.615px;" rowspan="1" colspan="1">
<p>Significant&#x000a0;alexia</p>
</td>
                <td style="width: 196.573px;" rowspan="1" colspan="1">
<p>Intact for simple items</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-82030.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluating a patient with PPA symptoms involves obtaining a detailed history and specific speech and language testing. A simplified 2-step process has been developed for standardization and ease of clinical diagnosis. The first step requires the patient to meet PPA requirements designed by Mesulam, which include a set of inclusion and exclusion criteria. Afterward, the diagnostic features crafted by Gorno-Tempini aid in distinguishing between the various types of PPA.<xref ref-type="bibr" rid="article-82030.r34">[34]</xref>&#x000a0;</p>
        <p>The Northwestern anagram test assesses grammar, often revealing impaired performance in patients with nfvPPA. The Montreal Cognitive Assessment test aids in evaluating cognitive decline, distinguishing it from dementia symptoms, but it must be used cautiously. Reduced verbal output and&#x000a0;AOS in nfvPPA may lower Montreal Cognitive Assessment scores, as can depression symptoms. Cognitive assessment alongside detailed speech and language examination is crucial. Following diagnosis, the progressive aphasia severity scale helps clinicians track progression and symptom characterization in people with PPA.<xref ref-type="bibr" rid="article-82030.r35">[35]</xref></p>
        <p>Imaging may also be helpful. Fludeoxyglucose positron emission tomography (FDG-PET) is often used with brain MRI to evaluate primary progressive aphasias. The Broca area and insular cortex are most affected in the nfvPPA, though temporal and parietal hypometabolism are usually absent.</p>
        <p>
<bold>Neuroimaging Findings</bold>
</p>
        <p>Brain MRI and FDG-PET scans are the most important neuroimaging studies for PPA. The findings in each PPA variant are explained below (see <bold>Image</bold>. Primary Progressive Aphasia Variants).</p>
        <p>
<bold>Neuroimaging for NfvPPA</bold>
</p>
        <p>Patients with nfvPPA typically exhibit more atrophy and hypometabolism, primarily affecting the dominant posterior frontal lobe. The left inferior frontal gyrus (pars opercularis) is considered the syndrome-specific epicenter in nfvPPA.<xref ref-type="bibr" rid="article-82030.r36">[36]</xref><xref ref-type="bibr" rid="article-82030.r37">[37]</xref>&#x000a0;Additionally, the condition is associated with gray matter atrophy in the insula, premotor regions, supplementary motor area, and striatum. DWI reveals involvement of the dorsal language pathway, primarily comprising long-range white-matter fibers connecting frontal, subcortical, and parietal areas, in nfvPPA neurodegeneration.<xref ref-type="bibr" rid="article-82030.r38">[38]</xref>&#x000a0;Brain MRI has a low sensitivity at 29% but a high specificity at 91%. On the other hand, FDG-PET has roughly 67% sensitivity and 92% specificity.</p>
        <p>
<bold>Neuroimaging for SvPPA</bold>
</p>
        <p>Brain MRI and FDG-PET show atrophy and hypometabolism in the anterior temporal lobes, especially the temporal poles in patients with svPPA.<xref ref-type="bibr" rid="article-82030.r39">[39]</xref>&#x000a0;This focal anatomical damage makes neuroimaging a complementary tool in the diagnostic process for this PPA variant.<xref ref-type="bibr" rid="article-82030.r40">[40]</xref>&#x000a0;Brain MRI has good sensitivity (98%) and specificity (93%). By comparison, FDG-PET has close to 100% sensitivity and specificity. The damage is usually more significant in the left hemisphere during the disease's first stages.<xref ref-type="bibr" rid="article-82030.r41">[41]</xref>&#x000a0;</p>
        <p>
<bold>Neuroimaging for LvPPA</bold>
</p>
        <p>Anatomical damage in lvPPA is typically located in the posterior superior temporal and middle temporal gyri and the inferior parietal lobule.<xref ref-type="bibr" rid="article-82030.r42">[42]</xref>&#x000a0;This atrophy pattern is consistent with the classical anatomical model of the phonological loop. The condition's neurodegenerative pattern is highly similar to the one observed in early-onset Alzheimer disease.<xref ref-type="bibr" rid="article-82030.r43">[43]</xref>&#x000a0;Brain MRI has a low sensitivity at 57% but good specificity at 95%. FDG-PET is more sensitive at 92% and specific at 94%.</p>
      </sec>
      <sec id="article-82030.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>No medication has proven beneficial for PPA. Proper management of this condition begins with a detailed history and analysis of the patient&#x02019;s speech and language components. Contrary to previous beliefs, speech and language therapy may be considerably beneficial. Referral to a speech and language pathologist is essential for properly diagnosing language disorders and planning the appropriate treatment strategy. Speech and language therapy is the most effective PPA intervention, especially for AOS symptoms.<xref ref-type="bibr" rid="article-82030.r44">[44]</xref></p>
        <p>Transcranial direct current stimulation is seen as a promising intervention to enhance language therapy outcomes in PPA. This treatment's low cost, high safety, and noninvasiveness justify research into its potential to augment behavioral interventions and slow language decline in PPA.<xref ref-type="bibr" rid="article-82030.r45">[45]</xref></p>
      </sec>
      <sec id="article-82030.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The most important conditions that must be ruled out when considering PPA include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dementia: A patient may or may not have aphasia as part of dementia.&#x000a0;In contrast, PPA always has aphasia as the initial and primary symptom.</p>
          </list-item>
          <list-item>
            <p>Ischemic aphasia: An ischemic process will have symptoms of aphasia occurring more acutely. PPA has a slower course that can take years.</p>
          </list-item>
          <list-item>
            <p>Brain tumor: A brain tumor located at a site affecting speech and language may cause aphasia progressively as the lesion grows. Other complaints may include headache and sensorimotor weakness, both of which are often absent in PPA. Imaging&#x000a0;can also differentiate a tumor from PPA.</p>
          </list-item>
          <list-item>
            <p>Alzheimer disease: Dementia is an initial and prominent sign of&#x000a0;this condition. PPA rarely&#x000a0;has dementia at the onset of the disease process but has aphasia&#x000a0;as the primary and initial symptom.</p>
          </list-item>
          <list-item>
            <p>FTD: Dementia is the initial presenting symptom of FTD. In contrast,&#x000a0;PPA always has aphasia as the primary and initial manifestation. Dementia may develop,&#x000a0;though late in the illness course.</p>
          </list-item>
        </list>
        <p>A thorough history, physical examination, and diagnostic testing can help differentiate PPA from these clinical entities.</p>
      </sec>
      <sec id="article-82030.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>PPA is progressive, and no cure currently exists. Thus, patients eventually lose the ability to speak and understand both written and spoken language. Individuals with PPA are typically expected to have predominantly aphasic and apraxic symptoms initially. However, other cognitive and behavioral impairments develop as the disease progresses, usually no earlier than 8 to 12 years after initial symptom onset.<xref ref-type="bibr" rid="article-82030.r46">[46]</xref>&#x000a0;Individual prognostication is somewhat unreliable because of PPA's heterogeneity.</p>
        <p>Most patients with PPA live for 3 to 12 years after diagnosis. The mean survival from symptom onset for svPPA is 12 years, nfvPPA is 7.1 years, and lvPPA is 7.6 years. The most frequent cause of death is aspiration pneumonia.<xref ref-type="bibr" rid="article-82030.r47">[47]</xref></p>
      </sec>
      <sec id="article-82030.s11" sec-type="Complications">
        <title>Complications</title>
        <p>PPA's complications include the following:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Loss of the ability to speak and write</p>
          </list-item>
          <list-item>
            <p>Loss of the ability to understand written and spoken language</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Poor judgment</p>
          </list-item>
          <list-item>
            <p>Inappropriate social behavior</p>
          </list-item>
          <list-item>
            <p>Parkinsonism, hyperreflexia,&#x000a0;and corticobasal syndrome may occur but rarely</p>
          </list-item>
        </list>
        <p>Managing this condition's complications requires a multidisciplinary approach involving speech-language therapy, cognitive rehabilitation, psychosocial support, and caregiver education to optimize patient care and quality of life.</p>
      </sec>
      <sec id="article-82030.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultation with a neurologist, speech and language pathologist, speech therapist, social worker, and psychologist is necessary to optimize patient outcomes.</p>
      </sec>
      <sec id="article-82030.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Primary preventive measures for PPA focus on reducing the risks associated with neurodegenerative diseases and promoting brain health. These measures include maintaining a healthy lifestyle with a proper diet, regular exercise, and mental stimulation through activities like reading and puzzle-solving. Managing cardiovascular risk factors like hypertension, diabetes, and obesity is crucial, as cardiovascular health is closely linked to brain health. Additionally, protecting against head injuries and maintaining social connections can help preserve cognitive function and reduce the risk of cognitive decline.</p>
        <p>Secondary preventive measures for PPA involve early detection and management of underlying medical conditions potentially contributing to cognitive decline. Seeking medical advice if experiencing memory loss or language difficulties can lead to early diagnosis and intervention, which may help slow the progression of PPA and other neurodegenerative diseases. Regular medical check-ups and screenings can aid in detecting and managing risk factors such as hypertension, diabetes, and hypercholesterolemia.</p>
        <p>Patients with PPA and their families have an increased depression risk due to the condition's potentially earlier onset and progressive nature compared to Alzheimer disease. Patients' awareness of their deficits can exacerbate psychological distress. Psychological evaluation, education, and support conferences can assist patients and families in managing expectations, developing coping strategies, and receiving emotional support. Without a cure, patients may rely on social support for assistance with daily activities. Early intervention with appropriate treatment and support services can improve outcomes for people with PPA and their caregivers.</p>
      </sec>
      <sec id="article-82030.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>PPA presents a unique set of diagnostic and management challenges. Diagnosing this condition requires a comprehensive evaluation, including detailed language assessments and neuroimaging studies to identify specific neurodegenerative patterns. Subtyping PPA into its 3 main variants&#x02014;nfvPPA, svPPA, and lvPPA&#x02014;is crucial for tailoring interventions and predicting disease progression.</p>
        <p>Semantic memory deficits and fluent but empty speech characterize svPPA. Interventions focus on augmenting residual semantic knowledge through strategies like semantic cueing and categorization tasks. In contrast, nfvPPA manifests with effortful, agrammatic speech, often accompanied by AOS. Treatment for nfvPPA may involve speech therapy targeting grammatical structures and articulatory planning alongside compensatory strategies like using simplified language. LvPPA, typified by word-finding difficulties and impaired phonological processing, benefits from interventions that enhance phonological awareness and word retrieval, including phonological cueing and repetition exercises.</p>
        <p>Managing PPA requires a multidisciplinary approach. Collaborative efforts are essential for developing individualized treatment plans, providing support to patients and caregivers, and facilitating communication strategies to maintain functional abilities and quality of life throughout the disease course.</p>
      </sec>
      <sec id="article-82030.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with PPA are best managed with an interprofessional team approach. The relationships among the primary clinician, neurologist, and speech and language pathologist are critical. The precise evaluations provided by speech and language pathologists can more accurately diagnose a patient's presentation in a subject area with more fluid boundaries between particular diagnoses. The clinician can correlate the clinical findings with imaging findings to solidify the diagnosis. Treatment by speech and language pathologists provides the most significant potential for improvement.&#x000a0;Proper management also requires close communication with the clinician to better monitor development and new findings that may need to be addressed several years after the initial symptom presentation. PPA may require psychological and psychiatric intervention for&#x000a0;patients who develop significant depression later in the illness course.</p>
      </sec>
      <sec id="article-82030.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=82030&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=82030">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/primary-progressive-aphasia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=82030">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/82030/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=82030">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-82030.s17">
        <fig id="article-82030.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Primary Progressive Aphasia Variants. This illustration shows areas of reduced cortical thickness observed in semantic variant primary progressive aphasia (svPPA), logopenic variant primary progressive aphasia (lvPPA), and nonfluent variant primary progressive aphasia (nfvPPA) compared to healthy controls. Corrected p-values at the vertex- and cluster-levels are indicated with red/yellow and blue colors, respectively. Contributed fromRoutier A, Habert MO, Bertrand A, et al. Structural, microstructural, and metabolic alterations in primary progressive aphasia variants. <italic toggle="yes">Front Neurol.</italic> 2018;9:766. doi: 10.3389/fneur.2018.00766.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PPA" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-82030.s18">
        <title>References</title>
        <ref id="article-82030.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mesulam</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Slowly progressive aphasia without generalized dementia.</article-title>
            <source>Ann Neurol</source>
            <year>1982</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>592</fpage>
            <page-range>592-8</page-range>
            <pub-id pub-id-type="pmid">7114808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Hillis</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kertesz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mendez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cappa</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Ogar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rohrer</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boeve</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Manes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Vandenberghe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rascovsky</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Knopman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mesulam</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Classification of primary progressive aphasia and its variants.</article-title>
            <source>Neurology</source>
            <year>2011</year>
            <month>Mar</month>
            <day>15</day>
            <volume>76</volume>
            <issue>11</issue>
            <fpage>1006</fpage>
            <page-range>1006-14</page-range>
            <pub-id pub-id-type="pmid">21325651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rogalski</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mesulam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>An update on primary progressive aphasia.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>388</fpage>
            <page-range>388-92</page-range>
            <pub-id pub-id-type="pmid">17764628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habib</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pelletier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Primary progressive aphasia (Mesulam syndrome)].</article-title>
            <source>Presse Med</source>
            <year>1993</year>
            <month>May</month>
            <day>1-8</day>
            <volume>22</volume>
            <issue>16</issue>
            <fpage>757</fpage>
            <page-range>757-64</page-range>
            <pub-id pub-id-type="pmid">8316530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonner</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ash</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The new classification of primary progressive aphasia into semantic, logopenic, or nonfluent/agrammatic variants.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>484</fpage>
            <page-range>484-90</page-range>
            <pub-id pub-id-type="pmid">20809401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Botha</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Josephs</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Primary Progressive Aphasias and Apraxia of Speech.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-127</page-range>
            <pub-id pub-id-type="pmid">30707189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ulugut</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pijnenburg</surname>
                <given-names>YAL</given-names>
              </name>
            </person-group>
            <article-title>Frontotemporal dementia: Past, present, and future.</article-title>
            <source>Alzheimers Dement</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>5253</fpage>
            <page-range>5253-5263</page-range>
            <pub-id pub-id-type="pmid">37379561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yue</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rosa-Neto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Atrophy network mapping of clinical subtypes and main symptoms in frontotemporal dementia.</article-title>
            <source>Brain</source>
            <year>2024</year>
            <month>Sep</month>
            <day>03</day>
            <volume>147</volume>
            <issue>9</issue>
            <fpage>3048</fpage>
            <page-range>3048-3058</page-range>
            <pub-id pub-id-type="pmid">38426222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spinelli</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Mandelli</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Santos-Santos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Agosta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Grinberg</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Trojanowski</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Filippi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Seeley</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Typical and atypical pathology in primary progressive aphasia variants.</article-title>
            <source>Ann Neurol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>430</fpage>
            <page-range>430-443</page-range>
            <pub-id pub-id-type="pmid">28133816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Josephs</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Snowden</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mackenzie</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Neuropathological background of phenotypical variability in frontotemporal dementia.</article-title>
            <source>Acta Neuropathol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>122</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-53</page-range>
            <pub-id pub-id-type="pmid">21614463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chare</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Leyton</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>McGinley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Kril</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Halliday</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>85</volume>
            <issue>8</issue>
            <fpage>865</fpage>
            <page-range>865-70</page-range>
            <pub-id pub-id-type="pmid">24421286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cioffi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Galimberti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barocco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Spallazzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fenoglio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Serpente</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arcaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gardini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scarpini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caffarra</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.</article-title>
            <source>J Alzheimers Dis</source>
            <year>2016</year>
            <month>Sep</month>
            <day>06</day>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>717</fpage>
            <page-range>717-21</page-range>
            <pub-id pub-id-type="pmid">27567822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grossman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The non-fluent/agrammatic variant of primary progressive aphasia.</article-title>
            <source>Lancet Neurol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>545</fpage>
            <page-range>545-55</page-range>
            <pub-id pub-id-type="pmid">22608668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mesulam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Krefft</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Gass</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Adamson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Bigio</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Hutton</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Graff-Radford</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families.</article-title>
            <source>Arch Neurol</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-7</page-range>
            <pub-id pub-id-type="pmid">17210807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Charuvastra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Shapira</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mendez</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Fluent versus nonfluent primary progressive aphasia: a comparison of clinical and functional neuroimaging features.</article-title>
            <source>Brain Lang</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-60</page-range>
            <pub-id pub-id-type="pmid">15896383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos-Santos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Iaccarino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ayakta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tammewar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lobach</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mandelli</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Spinelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Pressman</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>O'Neil</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lazaris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Grinberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seeley</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Jagust</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.</article-title>
            <source>JAMA Neurol</source>
            <year>2018</year>
            <month>Mar</month>
            <day>01</day>
            <volume>75</volume>
            <issue>3</issue>
            <fpage>342</fpage>
            <page-range>342-352</page-range>
            <pub-id pub-id-type="pmid">29309493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teichmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Migliaccio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Logopenic progressive aphasia beyond Alzheimer's--an evolution towards dementia with Lewy bodies.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-4</page-range>
            <pub-id pub-id-type="pmid">22967721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bekkhus-Wetterberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Br&#x000e6;khus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Norvik</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Winsnes</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Wyller</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Primary progressive aphasia.</article-title>
            <source>Tidsskr Nor Laegeforen</source>
            <year>2022</year>
            <month>Nov</month>
            <day>22</day>
            <volume>142</volume>
            <issue>17</issue>
            <pub-id pub-id-type="pmid">36416646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mouton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plonka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fabre</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Robert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Macoir</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manera</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gros</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The course of primary progressive aphasia diagnosis: a cross-sectional study.</article-title>
            <source>Alzheimers Res Ther</source>
            <year>2022</year>
            <month>May</month>
            <day>10</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <pub-id pub-id-type="pmid">35538502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pengo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alberici</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Libri</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Benussi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gadola</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ashton</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Zetterberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Blennow</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Borroni</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Sex influences clinical phenotype in frontotemporal dementia.</article-title>
            <source>Neurol Sci</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>9</issue>
            <fpage>5281</fpage>
            <page-range>5281-5287</page-range>
            <pub-id pub-id-type="pmid">35672480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marshall</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Hardy</surname>
                <given-names>CJD</given-names>
              </name>
              <name>
                <surname>Volkmer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Bond</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Mummery</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Schott</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rossor</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Crutch</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Rohrer</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Primary progressive aphasia: a clinical approach.</article-title>
            <source>J Neurol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>265</volume>
            <issue>6</issue>
            <fpage>1474</fpage>
            <page-range>1474-1490</page-range>
            <pub-id pub-id-type="pmid">29392464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Brambati</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Progressive nonfluent aphasia and its characteristic motor speech deficits.</article-title>
            <source>Alzheimer Dis Assoc Disord</source>
            <year>2007</year>
            <season>Oct-Dec</season>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>S23</fpage>
            <page-range>S23-30</page-range>
            <pub-id pub-id-type="pmid">18090419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ash</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>O'Shea</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Haley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McMillan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Irwin</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rascovsky</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Differentiating primary progressive aphasias in a brief sample of connected speech.</article-title>
            <source>Neurology</source>
            <year>2013</year>
            <month>Jul</month>
            <day>23</day>
            <volume>81</volume>
            <issue>4</issue>
            <fpage>329</fpage>
            <page-range>329-36</page-range>
            <pub-id pub-id-type="pmid">23794681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ash</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McMillan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gunawardena</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Avants</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Speech errors in progressive non-fluent aphasia.</article-title>
            <source>Brain Lang</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-20</page-range>
            <pub-id pub-id-type="pmid">20074786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Besbris</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ogar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Jarrold</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Connected speech production in three variants of primary progressive aphasia.</article-title>
            <source>Brain</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>133</volume>
            <issue>Pt 7</issue>
            <fpage>2069</fpage>
            <page-range>2069-88</page-range>
            <pub-id pub-id-type="pmid">20542982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Allison</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ogar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Amici</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Behavioral features in semantic dementia vs other forms of progressive aphasias.</article-title>
            <source>Neurology</source>
            <year>2006</year>
            <month>Nov</month>
            <day>28</day>
            <volume>67</volume>
            <issue>10</issue>
            <fpage>1752</fpage>
            <page-range>1752-6</page-range>
            <pub-id pub-id-type="pmid">17130406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caine</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Breen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Emergence and progression of 'non-semantic' deficits in semantic dementia.</article-title>
            <source>Cortex</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>483</fpage>
            <page-range>483-94</page-range>
            <pub-id pub-id-type="pmid">19231477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garrard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rentoumi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gesierich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Machine learning approaches to diagnosis and laterality effects in semantic dementia discourse.</article-title>
            <source>Cortex</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>55</volume>
            <fpage>122</fpage>
            <page-range>122-9</page-range>
            <pub-id pub-id-type="pmid">23876449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yi</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Reversal of the concreteness effect for verbs in patients with semantic dementia.</article-title>
            <source>Neuropsychology</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-19</page-range>
            <pub-id pub-id-type="pmid">17201526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irish</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bunk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kamminga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hornberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piguet</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Preservation of episodic memory in semantic dementia: The importance of regions beyond the medial temporal lobes.</article-title>
            <source>Neuropsychologia</source>
            <year>2016</year>
            <month>Jan</month>
            <day>29</day>
            <volume>81</volume>
            <fpage>50</fpage>
            <page-range>50-60</page-range>
            <pub-id pub-id-type="pmid">26683384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irish</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Piguet</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Right anterior temporal lobe dysfunction underlies theory of mind impairments in semantic dementia.</article-title>
            <source>Brain</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>137</volume>
            <issue>Pt 4</issue>
            <fpage>1241</fpage>
            <page-range>1241-53</page-range>
            <pub-id pub-id-type="pmid">24523434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Brambati</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ginex</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ogar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Marcone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perani</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garibotto</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cappa</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>The logopenic/phonological variant of primary progressive aphasia.</article-title>
            <source>Neurology</source>
            <year>2008</year>
            <month>Oct</month>
            <day>14</day>
            <volume>71</volume>
            <issue>16</issue>
            <fpage>1227</fpage>
            <page-range>1227-34</page-range>
            <pub-id pub-id-type="pmid">18633132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leyton</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mioshi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Cognitive decline in logopenic aphasia: more than losing words.</article-title>
            <source>Neurology</source>
            <year>2013</year>
            <month>Mar</month>
            <day>05</day>
            <volume>80</volume>
            <issue>10</issue>
            <fpage>897</fpage>
            <page-range>897-903</page-range>
            <pub-id pub-id-type="pmid">23390170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinogradova</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Serov</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Sivakov</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>[Clinico-morphologic characteristics of periodic disease].</article-title>
            <source>Arkh Patol</source>
            <year>1975</year>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>70</fpage>
            <page-range>70-5</page-range>
            <pub-id pub-id-type="pmid">1131061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henry</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Grasso</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Individuals with Primary Progressive Aphasia.</article-title>
            <source>Semin Speech Lang</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>231</fpage>
            <page-range>231-241</page-range>
            <pub-id pub-id-type="pmid">29933490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandelli</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Vilaplana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Binney</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Attygalle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Santos-Santos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Pakvasa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Seeley</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.</article-title>
            <source>Brain</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>139</volume>
            <issue>Pt 10</issue>
            <fpage>2778</fpage>
            <page-range>2778-2791</page-range>
            <pub-id pub-id-type="pmid">27497488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandelli</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Vitali</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gola</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Seeley</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Two insular regions are differentially involved in behavioral variant FTD and nonfluent/agrammatic variant PPA.</article-title>
            <source>Cortex</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>74</volume>
            <fpage>149</fpage>
            <page-range>149-57</page-range>
            <pub-id pub-id-type="pmid">26673947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandelli</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Caverzasi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Binney</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lobach</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Block</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Amirbekian</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Frontal white matter tracts sustaining speech production in primary progressive aphasia.</article-title>
            <source>J Neurosci</source>
            <year>2014</year>
            <month>Jul</month>
            <day>16</day>
            <volume>34</volume>
            <issue>29</issue>
            <fpage>9754</fpage>
            <page-range>9754-67</page-range>
            <pub-id pub-id-type="pmid">25031413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galton</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lambon-Ralph</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Antoun</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sahakian</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia.</article-title>
            <source>Neurology</source>
            <year>2001</year>
            <month>Jul</month>
            <day>24</day>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>216</fpage>
            <page-range>216-25</page-range>
            <pub-id pub-id-type="pmid">11468305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shang</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Quantitative meta-analysis of gray matter abnormalities in semantic dementia.</article-title>
            <source>J Alzheimers Dis</source>
            <year>2012</year>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>827</fpage>
            <page-range>827-33</page-range>
            <pub-id pub-id-type="pmid">22699847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Rankin</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report.</article-title>
            <source>Neurocase</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-36</page-range>
            <pub-id pub-id-type="pmid">15788282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Dronkers</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Rankin</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Ogar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Phengrasamy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Cognition and anatomy in three variants of primary progressive aphasia.</article-title>
            <source>Ann Neurol</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>335</fpage>
            <page-range>335-46</page-range>
            <pub-id pub-id-type="pmid">14991811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Migliaccio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agosta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rascovsky</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Karydas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonasera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Gorno-Tempini</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.</article-title>
            <source>Neurology</source>
            <year>2009</year>
            <month>Nov</month>
            <day>10</day>
            <volume>73</volume>
            <issue>19</issue>
            <fpage>1571</fpage>
            <page-range>1571-8</page-range>
            <pub-id pub-id-type="pmid">19901249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cad&#x000f3;rio</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lousada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Generalization and maintenance of treatment gains in primary progressive aphasia (PPA): a systematic review.</article-title>
            <source>Int J Lang Commun Disord</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>543</fpage>
            <page-range>543-560</page-range>
            <pub-id pub-id-type="pmid">28120406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tippett</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Hillis</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Tsapkini</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Primary Progressive Aphasia.</article-title>
            <source>Curr Treat Options Neurol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>8</issue>
            <fpage>362</fpage>
            <pub-id pub-id-type="pmid">26062526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mesulam</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Primary progressive aphasia--differentiation from Alzheimer's disease.</article-title>
            <source>Ann Neurol</source>
            <year>1987</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>533</fpage>
            <page-range>533-4</page-range>
            <pub-id pub-id-type="pmid">3324947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-82030.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tastevin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lavoie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de la Sablonni&#x000e8;re</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carrier-Auclair</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Laforce</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Survival in the Three Common Variants of Primary Progressive Aphasia: A Retrospective Study in a Tertiary Memory Clinic.</article-title>
            <source>Brain Sci</source>
            <year>2021</year>
            <month>Aug</month>
            <day>24</day>
            <volume>11</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">34573135</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
